Cargando…

Discovery and validation of breast cancer subtypes

Mostrar otras versiones (1)

Following the publication of our recent article (Kapp et al., BMC Genomics 2006, 7:231), we (the authors) regrettably found several errors in the published Table 5. This correction article not only describes what makes the published Table 5 incorrect, it also presents the correct Table 5.

Detalles Bibliográficos
Autores principales:	Kapp, Amy V, Jeffrey, Stefanie S, Langerød, Anita, Børresen-Dale, Anne-Lise, Han, Wonshik, Noh, Dong-Young, Bukholm, Ida RK, Nicolau, Monica, Brown, Patrick O, Tibshirani, Robert
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855057/ http://dx.doi.org/10.1186/1471-2164-8-101

Ejemplares similares

Discovery and validation of breast cancer subtypes
por: Kapp, Amy V, et al.
Publicado: (2006)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004)

Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue
por: Quigley, David A., et al.
Publicado: (2017)

Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer
por: Sørby, Lise Aa, et al.
Publicado: (2010)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
por: Holstege, Henne, et al.
Publicado: (2010)

Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells
por: Eftang, Lars L, et al.
Publicado: (2012)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
por: Eftang, Lars L, et al.
Publicado: (2013)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
por: Chanock, Stephen J, et al.
Publicado: (2007)

Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis
por: Zhao, Hongjuan, et al.
Publicado: (2002)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
por: Beck, Andrew H, et al.
Publicado: (2009)

Correction: Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2021)

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
por: Sørlie, Therese, et al.
Publicado: (2006)

Correction: Concentration Determination of >200 Proteins in Dried Blood Spots for Biomarker Discovery and Validation
por: Eshghi, Azad, et al.
Publicado: (2020)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

Correction: MicroRNA-Based Promotion of Human Neuronal Differentiation and Subtype Specification
por: Stappert, Laura, et al.
Publicado: (2013)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
por: Terkelsen, Thilde, et al.
Publicado: (2021)

Correction: Identifying and validating subtypes within major psychiatric disorders based on frontal–posterior functional imbalance via deep learning
por: Chang, Miao, et al.
Publicado: (2020)

Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
por: McNamara, Keely M, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1m1t3llcsnshvsrd2hqrf8p12e